Eli Lilly and Co (LLY) Stock News

Rosen Law Firm is reminding investors who purchased Datavault AI Inc. securities between September 4, 2024 and October 30, 2025 of an important October 5, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that defendants made materially false statements regarding corporate partnerships, overstated trading activity on the Datavault Platform, and failed to disclose connections with a convicted felon, causing reputational harm.

The FDA has approved Eli Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in high-risk adults with type 2 diabetes. In a 13,299-patient study, Mounjaro showed an 8% lower MACE-3 rate than Trulicity, meeting non-inferiority objectives. With $18.6B in first-half 2026 sales, this expanded indication could drive further growth and narrow the competitive gap with Novo Nordisk's Ozempic.

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against Alarum Technologies Ltd. (ALAR) for allegedly making false statements about its business. The lawsuit claims that Alarum's subsidiary NetNut was engaging in illegal activity by linking customer home internet devices into another network without consent, enabling cybercriminals to conceal their locations. The firm alleges these undisclosed activities materially heightened legal exposure and threatened business prospects. The lead plaintiff deadline is October 5, 2026.

Rosen Law Firm has filed class action lawsuits against Hyliion Holdings Corp. (HYLN) for alleged false statements regarding a business deal with a recently formed entity lacking actual operations, and potential insider trading by executives. A separate class action has been filed against Insulet Corporation (PODD) with an August 31, 2026 deadline for lead plaintiff motions. Both lawsuits allege material misstatements that caused investor losses.

Rosen Law Firm is alerting investors in Microvast Holdings (MVST) about a securities class action lawsuit with a September 21, 2026 lead plaintiff deadline. The lawsuit alleges that Microvast made materially false and misleading statements regarding margin targets, inventory management, and delays in the Huzhou Phase 3.2 expansion, causing investor losses.

A securities class action lawsuit has been filed against Pentwater Capital Management LP and its CEO Matthew Halbower, alleging they orchestrated a market manipulation scheme involving Avis Budget Group stock. The defendants, holding approximately 51% economic interest in Avis, allegedly engaged in aggressive stock purchases during February 2025 to April 2026 that triggered a short squeeze, artificially inflating the stock price and benefiting their holdings. Investors who purchased Avis securities during this period may be eligible for compensation, with a September 29, 2026 deadline to serve as lead plaintiff.

Rosen Law Firm announces securities class action lawsuits against multiple companies. Verra Mobility is accused of making false statements about its relationship with Avis Budget Group and concealing material adverse facts. Hub Group and Alarum Technologies are also subjects of investigations for potential securities violations. Investors are urged to secure counsel before upcoming deadlines.

Rosen Law Firm reminds investors in Futu Holdings Limited of the August 25, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Futu made materially false statements regarding compliance with China Securities Regulatory Commission requirements, failed to disclose regulatory risks, and overstated financial results. Investors who purchased securities between May 24, 2023 and May 27, 2026 may be eligible for compensation.

A class action lawsuit has been filed against Citadel Securities LLC and Virtu Americas LLC on behalf of Genius Group Limited investors. The defendants are accused of engaging in 'spoofing'—submitting and canceling buy/sell orders without intent to execute them—to manipulate Genius stock prices and mislead market participants. The lead plaintiff deadline is August 28, 2026. Investors who purchased or sold Genius securities between April 12, 2022 and May 30, 2025 may be eligible for compensation.

Rosen Law Firm reminds GeneDx Holdings Corp. (NASDAQ: WGS) investors who purchased stock between April 16, 2025 and May 4, 2026 of the August 3, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges GeneDx made false statements regarding the Fabric acquisition's positive impact on the company's financials and operations, when defendants knew of significant viability problems that would negatively impact the business.

Rosen Law Firm has filed a class action lawsuit against PROCEPT BioRobotics Corporation on behalf of investors who purchased common stock between February 28, 2024 and February 25, 2026. The lawsuit alleges that PROCEPT made materially false statements regarding its handpiece unit sales and revenues by utilizing an undisclosed discount program that artificially inflated sales figures and created excess inventory of over 10,000 units. The company allegedly failed to disclose these risks and was unable to achieve its 2025 guidance. Investors must move the court by September 22, 2026 to serve as lead plaintiff.

A securities class action lawsuit has been filed against First Solar, Inc. for allegedly making materially false and misleading statements regarding its capacity to manage U.S. tariff policy impacts and overstating projected performance. The lawsuit covers purchases between February 26, 2025 and February 24, 2026. The lead plaintiff deadline is August 24, 2026.

Rosen Law Firm announces a securities class action lawsuit against Peabody Energy Corporation for allegedly providing false and misleading statements regarding its Centurion mine operations. The company significantly lowered guidance in March 2026, revealing that Q1 output would be approximately 250,000 tons instead of the previously estimated 700,000 tons due to mining commissioning challenges. Investors who purchased BTU stock between October 14, 2024 and May 4, 2026 may be eligible for compensation. The lead plaintiff deadline is August 24, 2026.

Rosen Law Firm is encouraging investors who suffered losses exceeding $100,000 in Futu Holdings Limited to join a securities class action lawsuit. The lawsuit alleges that Futu made materially false statements and failed to disclose non-compliance with China Securities Regulatory Commission requirements, including conducting securities and futures business without proper licenses. The lead plaintiff deadline is August 25, 2026.

Rosen Law Firm announces a securities class action lawsuit against Futu Holdings Limited, alleging the company made materially false statements and failed to disclose non-compliance with China Securities Regulatory Commission requirements. The lawsuit claims Futu conducted securities, public fund sales, and futures business in mainland China without proper licenses, leading to overstated financial results. Investors who purchased securities between May 24, 2023 and May 27, 2026 may be eligible for compensation, with a lead plaintiff deadline of August 25, 2026.

Rosen Law Firm is reminding investors who purchased Peabody Energy common stock between October 14, 2024 and May 4, 2026 of an important August 24, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Peabody Energy provided misleading statements about its Centurion mine operations, with the company significantly lowering guidance in March 2026 when actual output was approximately 250,000 tons versus previously estimated 700,000 tons due to mining commissioning challenges.

Rosen Law Firm is reminding investors in Black Rock Coffee Bar, Inc. (NASDAQ: BRCB) of an August 17, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that defendants made materially false statements and failed to disclose that new store openings were cannibalizing existing revenue through 'sales transfer,' which materially impacted financial results.

Rosen Law Firm is reminding investors in Via Transportation, Inc. (NYSE: VIA) of an August 10, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Via's IPO offering documents were false and misleading, omitting information about declining Platform Annual Run-Rate Revenue and inability to grow in Germany. Via shares have declined approximately 70% from the IPO price to $14.52.

Rosen Law Firm is alerting Sportradar Group AG investors who purchased shares between November 7, 2024 and April 21, 2026 about a July 17, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Sportradar made false statements about compliance and ethics while secretly working with black-market gambling operators and maintaining inadequate Know-Your-Customer processes.

Rosen Law Firm has filed a class action lawsuit on behalf of Genius Group Limited (GNS) investors who purchased or sold securities between April 12, 2022 and May 30, 2025. The lawsuit alleges that Citadel Securities LLC and Virtu Americas LLC engaged in illegal 'spoofing' practices—submitting and cancelling orders without intent to execute them—to manipulate stock prices and mislead market participants about supply, demand, and volatility. The deadline to serve as lead plaintiff is August 28, 2026.

Rosen Law Firm announces securities class action lawsuits against FS KKR Capital Corp. (FSK) and ChampionX Corporation (CHX). FSK investors with losses exceeding $100K are urged to act before the July 6, 2026 deadline, with allegations including overstated portfolio valuations and misleading statements about business operations. CHX has a similar deadline of July 14, 2026.

Rosen Law Firm announces securities class action lawsuits against AeroVironment, Calix, and Sportradar Group, alleging that defendants made false or misleading statements regarding business prospects and competitive positioning. Investors with losses exceeding $100K are encouraged to join the class actions before upcoming deadlines.

Rosen Law Firm is encouraging investors who purchased Badger Meter common stock between April 18, 2024 and April 16, 2026 to join a securities class action lawsuit. The lawsuit alleges that Badger Meter made materially false and misleading statements about its financial results and growth prospects by concealing a practice of pulling forward customer orders to recognize revenue early, which masked weakening demand and deteriorating order trends. The lead plaintiff deadline is August 3, 2026.

Rosen Law Firm has filed a class action lawsuit against Embecta Corp. on behalf of investors who purchased common stock between November 25, 2025 and May 4, 2026. The lawsuit alleges that Embecta made false and misleading statements about its fiscal results and guidance, particularly regarding its pen needle business, which it described as 'incredibly resolute' before subsequently missing expectations and cutting 2026 fiscal guidance. Investors who purchased shares during this period may be entitled to compensation. The deadline to serve as lead plaintiff is August 17, 2026.

Rosen Law Firm is encouraging investors who purchased securities of Nano-X Imaging Ltd. (NNOX) between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The firm alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and cash burn. The lead plaintiff deadline is August 11, 2026. The firm is also investigating potential securities claims for ADMA Biologics and DNOW Inc.

Rosen Law Firm is urging investors in Black Rock Coffee Bar, Inc. (NASDAQ: BRCB) to join a securities class action lawsuit with an August 17, 2026 deadline for lead plaintiff claims. The lawsuit alleges that defendants made materially false statements and failed to disclose that new store openings were cannibalizing existing revenue through 'sales transfer,' materially impacting financial results during the class period from September 12, 2025 to May 12, 2026.

Rosen Law Firm has filed a class action lawsuit against Black Rock Coffee Bar, Inc. (NASDAQ: BRCB) on behalf of investors who purchased securities during the company's September 2025 IPO and through May 12, 2026. The lawsuit alleges that defendants made materially false and misleading statements regarding the company's expansion strategy, failing to disclose that new store openings were cannibalizing existing revenue through 'sales transfer,' which materially impacted financial results. The deadline to serve as lead plaintiff is August 17, 2026.

Rosen Law Firm is reminding investors who purchased GRAIL, Inc. common stock between May 13, 2025 and February 19, 2026 of an important August 4, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that GRAIL provided overwhelmingly positive statements while concealing material adverse facts about its NHS-Galleri trial, including that the trial period was insufficient to demonstrate the primary endpoint of reducing Stage III-IV cancers.

Rosen Law Firm is reminding investors who purchased GRAIL, Inc. common stock between May 13, 2025 and February 19, 2026 of an important August 4, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that GRAIL provided overwhelmingly positive statements while concealing material adverse facts about its NHS-Galleri trial, including that the trial period was insufficient to demonstrate the primary endpoint of reducing Stage III-IV cancers.

Rosen Law Firm announces securities class action lawsuits against Regencell Bioscience Holdings Limited, Sportradar Group AG, and TruBridge, Inc. Investors with losses exceeding $100,000 are encouraged to join the litigation before the June 23, 2026 deadline. The lawsuits allege false and misleading statements regarding market manipulation, regulatory risks, and undisclosed material information.